The Toxicology Research Laboratory prides itself, in having a diverse, skilled and professional workforce. The laboratory is headed by Dr. Alexander V. Lyubimov, Director, TRL. The team currently consists of 3 M.D./Ph.D. Study Directors, 1 Laboratory Supervisor, 1 Senior Report Writer, 1 Quality Assurance Officer, 9 Laboratory Technicians and other administrative and support staff.

 

     

Alexander V. Lyubimov ,

 

M.D., Ph. D., D.A.B.T.

 

Director, TRL

Alexander Lyubimov, M.D., Ph.D., D.A.B.T., Director of the Toxicology Research Laboratory, Department of Pharmacology, College of Medicine , UIC, has more than 30 years of experience in the fields of toxicology and clinical pathology with more than 110 scientific publications and abstracts.  His research experience includes numerous acute, subchronic and chronic studies; reproductive and developmental toxicity studies; pharmacokinetics studies, in vivo and in vitro immunotoxicity and genotoxicity studies, as well as efficacy and safety studies of new medicines.  These studies have been conducted for both government and industry Sponsors and have included therapeutic agents such as antibiotics, anti-AIDS pharmaceuticals, gene therapies, bacterial agents, live cells, anticancer agents, chemoprevention drugs, imaging agents, chemical antidotes, cosmetics, solvents, pesticides, biomaterials, and environmental pollutants.

 

Julia Kaufman ,

 

B.S.

 

Laboratory Administrator, TRL

 

Julia Kaufman provides administrative support for TRL’s scientific programs. Her responsibilities include monitoring contracts and budgets for the UIC-TRL, and she works closely with the University Business Office and the Vice Chancellor’s Office for Research. She has 21 years experience in project management and 12 years accounting experience.

 

Kasim K. Kabirov,

 

M.D., Ph.D.

 

Study Director, TRL

Kasim Kabirov, M.D., Ph.D., Study Director, has more than 20 years of experience in the field of general and reproductive toxicology assessment and mutagenicity evaluation.  He has served as a Study Director for many male/female reproductive studies including early embryonic development and prenatal/postnatal studies.  He has experience in validation of analytical and biological methods, including ELISA, test article formulation analysis, Hershberger Assay, receptor binding assay and tissue analysis.  He has presented his research results at more than 30 scientific conferences and has more than 60 scientific publications and abstracts.

.

 

Matthew Lindeblad,

B.S.

Senior Toxicologist, Study Director and Systems Administrator, TRL

Matthew Lindeblad has 10 years of toxicology, pharmacology, cellular and molecular biology, and anticancer drug research experience. His toxicology research experience includes acute and subchronic studies in mice, rats, dogs and non-human primates; and developmental toxicity studies in rats and rabbits. He has also directed several studies in safety pharmacology research in dogs.  Additionally, he has several years of experience in veterinary medicine.  Mr. Lindeblad has presented several abstracts at various national and international level conferences.  Mr. Lindeblad has been with the Toxicology Research Laboratory since 1998 and has served as the Laboratory Supervisor and performed technical functions on many studies.  Mr. Lindeblad is a member of the Society of Toxicology.  Mr. Lindeblad is also responsible for the design and validation of the laboratory computer systems.  Mr. Lindeblad received his bachelors of science from Northern Illinois University with an emphasis in physiology and chemistry.